Kumamoto Hiroki, Fukano Misato, Nakano Tomohiko, Iwagami Keito, Takeyama Chiaki, Kohgo Satoru, Imoto Shuhei, Amano Masayuki, Kuwata-Higashi Nobuyo, Aoki Manabu, Abe Hiroshi, Mitsuya Hiroaki, Fukuhara Kiyoshi, Haraguchi Kazuhiro
School of Pharmacy, Showa University , 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555, Japan.
Center for Clinical Sciences, National Center for Global Health and Medicine , 1-21-1 Toyama, Shinjuku, Tokyo 162-8655, Japan.
J Org Chem. 2016 Apr 1;81(7):2827-36. doi: 10.1021/acs.joc.6b00105. Epub 2016 Mar 24.
A method for the diastereoselective synthesis of 6″-(Z)- and 6″-(E)-fluorinated analogues of the anti-HBV agent entecavir has been developed. Construction of the methylenecyclopentane skeleton of the target molecules has been accomplished by radical-mediated 5-exo-dig cyclization of the selenides 6 and 15 having the phenylsulfanylethynyl structure as a radical accepting moiety. In the radical reaction of the TBS-protected precursor 6, (Z)-anti-12 was formed as a major product. On the other hand, TIPS-protected 15 gave (E)-anti-12. The sulfur-extrusive stannylation of anti-12 furnished a mixture of geometric isomers of the respective vinylstannane, whereas benzoyl-protected 17 underwent the stannylation in the manner of retention of configuration. Following XeF2-mediated fluorination, introduction of the purine base and deoxygenation of the resulting carbocyclic guanosine gave the target (E)- and (Z)-3 after deprotection. Evaluation of the anti-HBV activity of 3 revealed that fluorine-substitution at the 6″-position of entecavir gave rise to a reduction in the cytotoxicity in HepG2 cells with retention of the antiviral activity.
已开发出一种非对映选择性合成抗乙肝病毒药物恩替卡韦的6″-(Z)-和6″-(E)-氟化类似物的方法。目标分子亚甲基环戊烷骨架的构建是通过具有苯硫基乙炔结构作为自由基接受部分的硒化物6和15的自由基介导的5-外向-环化反应完成的。在TBS保护的前体6的自由基反应中,(Z)-反式-12作为主要产物形成。另一方面,TIPS保护的15得到(E)-反式-12。反式-12的脱硫锡化反应得到相应乙烯基锡烷的几何异构体混合物,而苯甲酰保护的17以构型保留的方式进行锡化反应。在XeF₂介导的氟化反应之后,引入嘌呤碱基并将所得碳环鸟苷脱氧,脱保护后得到目标产物(E)-和(Z)-3。对3的抗乙肝病毒活性的评估表明,恩替卡韦6″位的氟取代导致HepG2细胞中的细胞毒性降低,同时保留了抗病毒活性。